SynthesisDrug design, development and therapy2016

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis.

Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.